Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is It Too Late to Buy Eli Lilly?


Eli Lilly (NYSE: LLY) stock has been winning big when it comes to earnings and stock performance in recent years. And this has a lot to do with the company's leadership in a type of drug that's taken the world by storm: GLP-1 drugs for weight loss. Lilly dominates the market, and its drugs have been bringing in blockbuster revenue.

With the obesity drug market on track to reach nearly $100 billion by the end of the decade, the success story may be far from over. Still, Lilly stock has climbed 400% over the past five years and now trades for more than $1,200. Is it too late to get in on shares of the pharma giant? Let's find out.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
LLY
Share

Comments